Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

West Valley City, Utah

Phase 1 colorectal cancer trials in West Valley City, UT

19 Phase 1 colorectal cancer studies are recruiting participants at sites in West Valley City as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

West Valley City at a glance

  • 19 studies are recruiting at a site in West Valley City.
  • By phase: Phase 1 (13), Phase 1/2 (6).
  • By sponsor: industry (19).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in West Valley City

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    START Mountain Region
    Registry record
    NCT06253871 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT07488676 · updated
  3. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT06004245 · updated
  4. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT06270706 · updated
  5. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    START Mountain Region, LLC
    Registry record
    NCT07503808 · updated
  6. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    START Mountain Region
    Registry record
    NCT07318805 · updated
  7. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    START Mountain Region
    Registry record
    NCT06400472 · updated
  8. Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Sairopa B.V.
    Study site
    Start Center for Cancer Research - Mountain Region
    Registry record
    NCT05856981 · updated
  9. First-in-human Study of 7MW4911 in GI Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Mabwell (Shanghai) Bioscience Co., Ltd.
    Study site
    START Moutain Region
    Registry record
    NCT07216560 · updated
  10. A Study of MGC026 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    START Mountain Region
    Registry record
    NCT06242470 · updated
  11. A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    ALX Oncology Inc.
    Study site
    ALX Center 4
    Registry record
    NCT07085091 · updated
  12. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    South Texas Accelerated Research Therapeutics Mountain Region
    Registry record
    NCT06131840 · updated
  13. A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Coherus Oncology, Inc.
    Study site
    START Mountain Region, LLC.
    Registry record
    NCT06657144 · updated
  14. A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    PAQ Therapeutics, Inc.
    Study site
    START Mountain Region
    Registry record
    NCT07300150 · updated
  15. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Start Mountain Region /ID# 276270
    Registry record
    NCT05005403 · updated
  16. A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    START Mountain Region
    Registry record
    NCT07223047 · updated
  17. A Study of MGC028 in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    MacroGenics
    Study site
    South Texas Accelerated Research Therapeutics (START) Mountain Region
    Registry record
    NCT06723236 · updated
  18. Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Tasca Therapeutics
    Study site
    START Mountain Region
    Registry record
    NCT07030257 · updated
  19. Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    MBrace Therapeutics
    Study site
    START, Mountain Region
    Registry record
    NCT07145255 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in West Valley City, UT on ClinicalTrials.gov.

Ask about studies near West Valley City

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Utah

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call